WCA
MDT icon

Waratah Capital Advisors’s Medtronic MDT Stock Holding History

Waratah Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-133,905
Closed -$13.2M – 131
2018
Q3 		$13.2M Buy
+133,905
New +$12.4M 1.32% 27

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Waratah Capital Advisors's MDT Position: Q4 2018 in Review

Waratah Capital Advisors sold out of Medtronic (MDT) in Q4 2018, closing a stake of 133,905 shares — an estimated $13.2M sold.

Waratah Capital Advisors first reported a position in MDT in Q3 2018 and held it in 1 quarter. The position peaked at $13.2M in Q3 2018. 1,563 funds tracked by Wall St. Rank hold MDT as of Q4 2018.

  • Waratah Capital Advisors reported no remaining Medtronic position as of Q4 2018 after selling out during the quarter.
  • Waratah Capital Advisors sold 133,905 Medtronic shares in Q4 2018, an estimated $13.2M.
  • Waratah Capital Advisors first reported a position in Medtronic in Q3 2018 and held it in 1 quarter.
  • Waratah Capital Advisors's Medtronic position peaked at $13.2M in Q3 2018.
  • 1,563 funds tracked by Wall St. Rank held Medtronic as of Q4 2018.

Based on Waratah Capital Advisors's 13F filing for Q4 2018, filed 6 Feb 2019.